The EASL–Lancet Liver Commission:protecting the next generation of Europeans against liver disease complications and premature mortality

Autor: Tom H Karlsen, Nick Sheron, Shira Zelber-Sagi, Patrizia Carrieri, Geoffrey Dusheiko, Elisabetta Bugianesi, Rachel Pryke, Sharon J Hutchinson, Bruno Sangro, Natasha K Martin, Michele Cecchini, Mae Ashworth Dirac, Annalisa Belloni, Miquel Serra-Burriel, Cyriel Y Ponsioen, Brittney Sheena, Alienor Lerouge, Marion Devaux, Nick Scott, Margaret Hellard, Henkjan J Verkade, Ekkehard Sturm, Giulio Marchesini, Hannele Yki-Järvinen, Chris D Byrne, Giovanni Targher, Aviad Tur-Sinai, Damon Barrett, Michael Ninburg, Tatjana Reic, Alison Taylor, Tim Rhodes, Carla Treloar, Claus Petersen, Christoph Schramm, Robert Flisiak, Marieta Y Simonova, Albert Pares, Philip Johnson, Alessandro Cucchetti, Isabel Graupera, Christos Lionis, Elisa Pose, Núria Fabrellas, Ann T Ma, Juan M Mendive, Vincenzo Mazzaferro, Harry Rutter, Helena Cortez-Pinto, Deirdre Kelly, Robyn Burton, Jeffrey V Lazarus, Pere Ginès, Maria Buti, Philip N Newsome, Patrizia Burra, Michael P Manns
Přispěvatelé: Karlsen T.H., Sheron N., Zelber-Sagi S., Carrieri P., Dusheiko G., Bugianesi E., Pryke R., Hutchinson S.J., Sangro B., Martin N.K., Cecchini M., Dirac M.A., Belloni A., Serra-Burriel M., Ponsioen C.Y., Sheena B., Lerouge A., Devaux M., Scott N., Hellard M., Verkade H.J., Sturm E., Marchesini G., Yki-Jarvinen H., Byrne C.D., Targher G., Tur-Sinai A., Barrett D., Ninburg M., Reic T., Taylor A., Rhodes T., Treloar C., Petersen C., Schramm C., Flisiak R., Simonova M.Y., Pares A., Johnson P., Cucchetti A., Graupera I., Lionis C., Pose E., Fabrellas N., Ma A.T., Mendive J.M., Mazzaferro V., Rutter H., Cortez-Pinto H., Kelly D., Burton R., Lazarus J.V., Gines P., Buti M., Newsome P.N., Burra P., Manns M.P., Repositório da Universidade de Lisboa, University of Oslo (UiO), King‘s College London, Tel Aviv Sourasky Medical Center [Te Aviv], Sciences Economiques et Sociales de la Santé & Traitement de l'Information Médicale (SESSTIM - U1252 INSERM - Aix Marseille Univ - UMR 259 IRD), Institut de Recherche pour le Développement (IRD)-Aix Marseille Université (AMU)-Institut National de la Santé et de la Recherche Médicale (INSERM), Institut des sciences de la santé publique [Marseille] (ISSPAM), University College of London [London] (UCL), Università degli studi di Torino = University of Turin (UNITO), Bewdley Medical Centre [Bewdley, UK] (BMC), Glasgow Caledonian University (GCU), Centro de Investigación Biomédica en Red en el Área temática de Enfermedades Hepáticas y Digestivas (CIBERehd), Liver Unit, Clínica Universitaria, CIBER-EHD, University of Bristol [Bristol], Organisation de Coopération et de Développement Economiques = Organisation for Economic Co-operation and Development (OCDE), University of Washington [Seattle], Public Health England [London], Universität Zürich [Zürich] = University of Zurich (UZH), Amsterdam UMC - Amsterdam University Medical Center, Burnet Institute [Melbourne, Victoria], Royal Prince Alfred Hospital [Sydney, Australia], University of Melbourne, University of Groningen [Groningen], University Children's Hospital of Tübingen, Partenaires INRAE, University hospital - Policlinico S.Orsola-Malpighi [Bologna, Italy], Helsingin yliopisto = Helsingfors universitet = University of Helsinki, University Hospital Southampton NHS Foundation Trust, Università degli studi di Verona = University of Verona (UNIVR), Max Stern Yezreel Valley college (YVC), University of Gothenburg (GU), World Hepatitis Alliance [London, UK] (WHA), European Liver Patients Organization [Brussels, Belgium] (ELPO), Croatian Society for Liver Diseases-Hepatos [Split, Croatia] (CSLDH), Children's Liver Disease Foundation [Birmingham, UK] (CLDF), London School of Hygiene and Tropical Medicine (LSHTM), University of New South Wales [Sydney] (UNSW), Hannover Medical School [Hannover] (MHH), Universitaetsklinikum Hamburg-Eppendorf = University Medical Center Hamburg-Eppendorf [Hamburg] (UKE), Medical University of Białystok (MUB), Medical Military Academy [Sofia, Bulgaria] (2MA), Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), University of Liverpool, University of Bologna/Università di Bologna, University of Crete [Heraklion] (UOC), University of Barcelona, Institute of Health Carlos III, Università degli Studi di Milano = University of Milan (UNIMI), University of Bath [Bath], Universidade de Lisboa = University of Lisbon (ULISBOA), University of Birmingham [Birmingham], Instituto de Salud Global - Institute For Global Health [Barcelona] (ISGlobal), Instituto de Salud Carlos III [Madrid] (ISC), Azienda Ospedale Università di Padova = Hospital-University of Padua (AOUP), Malbec, Odile
Jazyk: angličtina
Rok vydání: 2022
Předmět:
Zdroj: Karlsen, T H, Sheron, N, Zelber-Sagi, S, Carrieri, P, Dusheiko, G, Bugianesi, E, Pryke, R, Hutchinson, S J, Sangro, B, Martin, N K, Cecchini, M, Dirac, M A, Belloni, A, Serra-Burriel, M, Ponsioen, C Y, Sheena, B, Lerouge, A, Devaux, M, Scott, N, Hellard, M, Verkade, H J, Sturm, E, Marchesini, G, Yki-Järvinen, H, Byrne, C D, Targher, G, Tur-Sinai, A, Barrett, D, Ninburg, M, Reic, T, Taylor, A, Rhodes, T, Treloar, C, Petersen, C, Schramm, C, Flisiak, R, Simonova, M Y, Pares, A, Johnson, P, Cucchetti, A, Graupera, I, Lionis, C, Pose, E, Fabrellas, N, Ma, A T, Mendive, J M, Mazzaferro, V, Rutter, H, Cortez-Pinto, H, Kelly, D, Burton, R, Lazarus, J V, Ginès, P, Buti, M, Newsome, P N, Burra, P & Manns, M P 2022, ' The EASL–Lancet Liver Commission : protecting the next generation of Europeans against liver disease complications and premature mortality ', The Lancet, vol. 399, no. 10319, pp. 61-116 . https://doi.org/10.1016/S0140-6736(21)01701-3, https://doi.org/10.1016/S0140-6736(21)01701-3
LANCET
The Lancet
The Lancet, Elsevier, 2022, 399 (10319), pp.61-116. ⟨10.1016/S0140-6736(21)01701-3⟩
Lancet
r-FSJD. Repositorio Institucional de Producción Científica de la Fundació Sant Joan de Déu
instname
ISSN: 2001-0036
0140-6736
1474-547X
DOI: 10.1016/S0140-6736(21)01701-3
Popis: © 2021 Elsevier Ltd. All rights reserved.
Liver diseases have become a major health threat across Europe, and the face of European hepatology is changing due to the cure of viral hepatitis C and the control of chronic viral hepatitis B, the increasingly widespread unhealthy use of alcohol, the epidemic of obesity, and undiagnosed or untreated liver disease in migrant populations. Consequently, Europe is facing a looming syndemic, in which socioeconomic and health inequities combine to adversely affect liver disease prevalence, outcomes, and opportunities to receive care. In addition, the COVID-19 pandemic has magnified pre-existing challenges to uniform implementation of policies and equity of access to care in Europe, arising from national borders and the cultural and historical heterogeneity of European societies. In following up on work from the Lancet Commission on liver disease in the UK and epidemiological studies led by the European Association for the Study of the Liver (EASL), our multidisciplinary Commission, comprising a wide range of public health, medical, and nursing specialty groups, along with patient representatives, set out to provide a snapshot of the European landscape on liver diseases and to propose a framework for the principal actions required to improve liver health in Europe. We believe that a joint European process of thinking, and construction of uniform policies and action, implementation, and evaluation can serve as a powerful mechanism to improve liver care in Europe and set the way for similar changes globally.
The SHARE data collection has been funded by the European Commission through FP5 (QLK6-CT-2001-00360), FP6 (SHARE-I3: RII-CT-2006-062193; COMPARE: CIT5-CT-2005-028857; SHARELIFE: CIT4-CT-2006-028812), FP7 (SHARE-PREP: GA N°211909; SHARE-LEAP: GA N°227822; SHARE M4: GA N°261982; DASISH: GA N°283646), and Horizon 2020 (SHARE-DEV3: GA N°676536; SHARE-COHESION: GA N°870628; SERISS: GA N°654221; SSHOC: GA N°823782) and by DG Employment, Social Affairs & Inclusion. Additional funding from the German Ministry of Education and Research, the Max Planck Society for the Advancement of Science, the US National Institute on Aging (U01_AG09740-13S2; P01_AG005842; P01_AG08291; P30_AG12815; R21_AG025169; Y1-AG-4553-01; IAG_BSR06-11; OGHA_04-064; HHSN271201300071C), and from various national funding sources is gratefully acknowledged. PC acknowledges support by the French National Agency for HIV, hepatitis and emerging infectious diseases research (ANRS / EMERGING INFECTIOUS DISEASES).
Databáze: OpenAIRE
Externí odkaz: